Loading clinical trials...
Loading clinical trials...
Chronic alcoholic and metabolic liver diseases are the two main liver diseases in France. The long-term prognosis of these two diseases are not well known because main studies are retrospective and with only alcoholic patients. The knowledge of the natural history of these diseases should improve the management of patients with such diseases. The aim of this prospective cohort is to describe the natural history of patients with chronic liver disease due to alcohol or metabolic disease and to identify factors associated with complications of these liver diseases (cirrhosis, hepatocellular carcinoma, ascites. ..).
In 2010, the two most frequent chronic liver diseases are alcoholic and metabolic disease. The natural history of these two diseases is not well known. Indeed, most of the studies were retrospective and evaluated alcoholic disease or metabolic disease but never both diseases. However, these two diseases have the same histological lesions and can be associated. The knowledge of the natural history of these diseases could improve the management of patients in order to decrease complications and improve survival. The aim of this prospective study is to describe the natural history of chronic liver disease due to alcohol and/or metabolic syndrome and to identify factors associated with complications (ascites, encephalopathy, death, complications of obesity, diabetes or chronic alcohol abuse). All patients will be followed every 6 months for 3 years with clinical, biological and morphological parameters.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU d'Angers
Angers, France
CHU de Besançon - Hôpital Jean Minjoz
Besançon, France
CH Pierre Oudot
Bourgoin, France
CHU de Brest - Hôpital La Cavale Blanche
Brest, France
CHU de Caen
Caen, France
CH de Chateauroux
Châteauroux, France
CHU Clermont-Ferrand - Hôpital Estaing
Clermont-Ferrand, France
CH Laennec
Creil, France
CHU de Grenoble - Hôpital Albert Michallon
Grenoble, France
CH Le Mans
Le Mans, France
Start Date
November 23, 2010
Primary Completion Date
December 12, 2020
Completion Date
December 12, 2020
Last Updated
March 26, 2021
527
ACTUAL participants
Intervention according to the standard of care.
OTHER
Lead Sponsor
University Hospital, Bordeaux
NCT07420023
NCT05236374
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06493773